[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100562483":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":14,"locations":7,"responsibleParty":20,"collaborators":7,"id":24,"slug":25,"hasResults":26,"nctId":27,"briefTitle":28,"officialTitle":29,"acronym":7,"eligibilityCriteria":30,"healthyVolunteers":31,"sex":32,"minAge":33,"maxAge":34,"enrollmentInfo":35,"targetDuration":7,"studyType":38,"phases":7,"briefSummary":39,"conditions":40,"keywords":7,"overallStatus":42,"whyStopped":7,"lastUpdateSubmitDate":43,"lastUpdatePostDateStruct":44,"startDateStruct":47,"completionDateStruct":49,"leadSponsor":51,"locationsCount":7},{"fullName":5,"class":6},"Assiut University","OTHER",null,[9,12],{"name":10,"affiliation":5,"role":11},"Mahmoud A Ahmed, Dr","STUDY_DIRECTOR",{"name":13,"affiliation":5,"role":11},"Jaafar I Mohamad, Prof",[15],{"name":16,"role":17,"phone":18,"phoneExt":7,"email":19},"alaa A mohamed","CONTACT","800 555 5555","aboelhassanalaa209@gmail.com",{"type":21,"investigatorFullName":22,"investigatorTitle":23,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"SPONSOR_INVESTIGATOR","alaa aboelhassan mohamed aboelhassan","Assistant Lecturer","100562483","role-of-serum-ba-ratio-compared-to-tsb-for-early-prediction-of-bilirubin-induced-neurological-dysfunction-bind-100562483",false,"NCT06603753","Role of Serum (B\u002FA) Ratio Compared to (TSB) for Early Prediction of Bilirubin-induced Neurological Dysfunction (BIND).","Use of Serum Bilirubin\u002FAlbumin Ratio for Early Prediction of Bilirubin Induced Neurological Dysfunction","Inclusion Criteria:• Neonates with hyperbilirubinemia reached level of phototherapy or exchange transfusion according to the American Academy of Pediatrics guidelines \\[14\\].\n\n* Age: from 1 to 28 day.\n* Full term and preterm babies.\n* Both sexes.\n\nExclusion Criteria:\n\n* Conjugated hyperbilirubinemia.\n* Perinatal asphyxia.\n* Patients with encephalopathy due to causes other than hyperbilirubinemia.\n* Severe birth defects or congenital anomalies.\n* Hemodynamic instability.\n* Septic patients.",true,"ALL","1 Day","28 Days",{"count":36,"type":37},80,"ESTIMATED","OBSERVATIONAL","The aim of this study is to evaluate serum bilirubin\u002Falbumin (B\u002FA) ratio compared to total serum bilirubin (TSB) for early prediction of bilirubin-induced neurological dysfunction (BIND).",[41],"Hyperbilirubinemia, Neonatal","NOT_YET_RECRUITING","2024-09-17",{"date":45,"type":46},"2024-09-19","ACTUAL",{"date":48,"type":37},"2025-01-01",{"date":50,"type":37},"2026-07-01",{"name":22,"class":6}]